Telmisartan exerts anti-tumor effects by activating peroxisome proliferator-activated receptor-γ in human lung adenocarcinoma a549 cells

Molecules

Volumn 19, Issue 3, 2014, Pages 2862-2876

  Li, Juan ^a   Chen, Lin ^b   Yu, Ping ^a   Liu, Bin ^a   Zhu, Jiang ^a   Yang, Ye ^a  

^a SICHUAN CANCER HOSPITAL   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

(PPAR ); A549 cells; Intercellular adhesion molecule 1 (ICAM 1); Lung cancer; Matrix metalloprotease 9 (MMP 9); Peroxisome proliferator activated receptor ; Telmisartan

Indexed keywords

ANTINEOPLASTIC AGENT; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; DNA BINDING PROTEIN; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TELMISARTAN;

ADENOCARCINOMA; ARTICLE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HUMAN; LUNG ADENOCARCINOMA; LUNG TUMOR; METABOLISM; TUMOR CELL LINE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BENZIMIDAZOLES; BENZOATES; CELL LINE, TUMOR; CELL SURVIVAL; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; PPAR GAMMA; RNA, MESSENGER;

EID: 84896966584     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19032862     Document Type: Article

References (39)

1. Rosenson, R.S.; Wright, R.S.; Farkouh, M.; Plutzky, J. Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects. Am. Heart J. 2012, 164, 672-680.
2. Choi, J.M.; Bothwell, A.L. The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases. Mol. Cell 2012, 33, 217-222.
3. Sugawara, A.; Uruno, A.; Matsuda, K.; Saito-Ito, T.; Funato, T.; Saito-Hakoda, A.; Kudo, M.; Ito, S. Effects of PPAR? agonists against vascular and renal dysfunction. Curr. Mol. Pharmacol. 2012, 5, 248-254.
4. Bishop-Bailey, D. PPARs and angiogenesis. Biochem. Soc. Trans. 2011, 39, 1601-1605.
5. Xiao, M.; Zhu, T.; Wang, T.; Wen, F.Q. Diammonium glycyrrhizinate inhibits airway smooth muscle proliferation in a murine model of chronic asthma. Nan Fang. Yi Ke Da Xue Xue Bao 2013, 33, 1416-1420.
6. Deng, Y.L.; Xiong, X.Z.; Cheng, N.S. Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator- activated receptor ? agonists. Hepatobiliary Pancreat. Dis. Int. 2012, 11, 467-478.
7. Yeh, S.L.; Yeh, C.L.; Chan, S.T.; Chuang, C.H. Plasma rich in quercetin metabolites induces G2/M arrest by upregulating PPAR-? expression in human A549 lung cancer cells. Planta Med. 2011, 77, 992-998.
8. Girnun, G.D. The diverse role of the PPAR? coactivator 1 family of transcriptional coactivators in cancer. Semin. Cell Dev. Biol. 2012, 23, 381-388.
9. Peters, J.M.; Shah, Y.M.; Gonzalez, F.J. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat. Rev. Cancer 2012, 12, 181-195.
10. Thompson, E.A. PPARgamma physiology and pathology in gastrointestinal epithelial cells. Mol. Cell 2007, 24, 167-176.
11. Wang, D.; Dubois, R.N. Peroxisome proliferator-activated receptors and progression of colorectal cancer. PPAR Res. 2008, 931074.
12. Robbins, G.T.; Nie, D. PPAR gamma, bioactive lipids, and cancer progression. Front. Biosci. 2012, 17, 1816-1834.
13. Yates, C.M.; McGettrick, H.M.; Nash, G.B.; Rainger, G.E. Adhesion of tumor cells to matrices and endothelium. Methods Mol. Biol. 2014, 1070, 57-75.
14. Hung, P.F.; Hong, T.M.; Hsu, Y.C.; Chen, H.Y.; Chang, Y.L.; Wu, C.T.; Chang, G.C.; Jou, Y.S.; Pan, S.H.; Yang, P.C. The motor protein KIF14 inhibits tumor growth and cancer metastasis in lung adenocarcinoma. PLoS One 2013, 8, e61664.
15. Jia, W.; Martin, T.A.; Zhang, G.; Jiang, W.G. Junctional adhesion molecules in cerebral endothelial tight junction and brain metastasis. Anticancer Res. 2013, 33, 2353-2359.
16. Liu, S.Q.; Su, Y.J.; Qin, M.B.; Mao, Y.B.; Huang, J.A.; Tang, G.D. Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules. Int. J. Oncol. 2013, 42, 617-626.
17. Zheng, F.J.; Shi, L.; Yang, J.; Deng, X.H.; Wu, Y.Q.; Yan, X.Q.; Huang, N. Effect of tea polyphenols on the adhesion of highly metastatic human lung carcinoma cell lines to endothelial cells in vitro. Asian Pac. J. Cancer Prev. 2012, 13, 3751-3755.
18. Traub, S.; Nikonova, A.; Carruthers, A.; Dunmore, R.; Vousden, K.A.; Gogsadze, L.; Hao, W.; Zhu, Q.; Bernard, K.; Zhu, J.; et al. An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation. PLoS Pathog. 2013, 9, e1003520.
19. Zumwalde, N.A.; Domae, E.; Mescher, M.F.; Shimizu, Y. ICAM-1-dependent homotypic aggregates regulate CD8 T cell effector function and differentiation during T cell activation. J. Immunol. 2013, 191, 3681-3693.
20. Dorecka, M.; Siemianowicz, K.; Francuz, T.; Garczorz, W.; Chyra, A.; Klych, A.; Romaniuk, W. Exendin-4 and GLP-1 decreases induced expression of ICAM-1, VCAM-1 and RAGE in human retinal pigment epithelial cells. Pharmacol. Rep. 2013, 65, 884-890.
21. Yu, J.A.; Sadaria, M.R.; Meng, X.; Mitra, S.; Ao, L.; Fullerton, D.A.; Weyant, M.J. Lung cancer cell invasion and expression of intercellular adhesion molecule-1 (ICAM-1) are attenuated by secretory phospholipase A2 inhibition. J. Thorac. Cardiovasc. Surg. 2012, 143, 405-411.
22. Lin, Y.C.; Shun, C.T.; Wu, M.S.; Chen, C.C. A novel anticancer effect of thalidomide: Inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kappaB. Clin. Cancer Res. 2006, 12, 7165-7173.
23. Kotteas, E.A.; Gkiozos, I.; Tsagkouli, S.; Bastas, A.; Ntanos, I.; Saif, M.W.; Syrigos, K.N. Soluble ICAM-1 levels in small-cell lung cancer: Prognostic value for survival and predictive significance for response during chemotherapy. Med. Oncol. 2013, 30, 662.
24. Cianchetti, S.; del Fiorentino, A.; Colognato, R.; di Stefano, R.; Franzoni, F.; Pedrinelli, R. Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells. Atherosclerosis 2008, 198, 22-28.
25. Celinski, K.; Madro, A.; Prozorow-Król, B.; Korolczuk, A.; Cichoz-Lach, H.; Slomka, M.; Korobowicz, E. Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma)- specific agonist, as a modulator in experimental acute pancreatitis. Med. Sci. Monit. 2009, 15, BR21-BR29.
26. Arnold, R.; Neumann, M.; König, W. Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells. Immunology 2007, 121, 71-81.
27. Verma, R.P.; Hansch, C. Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q)SARs. Bioorg. Med. Chem. 2007, 15, 2223-2268.
28. Gao, X.H.; Yang, X.Q.; Wang, B.C.; Liu, S.P.; Wang, F.B. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer. Asian Pac. J. Cancer Prev. 2013, 14, 5055-5060.
29. Ramanujum, R.; Lin, Y.L.; Liu, J.K.; He, S. Regulatory expression of MMP-8/MMP-9 and inhibition of proliferation, migration and invasion in human lung cancer A549 cells in the presence of HGF variants. Kaohsiung J. Med. Sci. 2013, 29, 530-539.
30. Xue, J.; Hua, Y.N.; Xie, M.L.; Gu, Z.L. Aspirin inhibits MMP-9 mRNA expression and release via the PPARalpha/gamma and COX-2/mPGES-1-mediated pathways in macrophages derived from THP-1 cells. Biomed. Pharmacother. 2010, 64, 118-123.
31. Marx, N.; Froehlich, J.; Siam, L.; Ittner, J.; Wierse, G.; Schmidt, A.; Scharnagl, H.; Hombach, V.; Koenig, W. Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 283-288.
32. Liu, J.; Lu, H.; Huang, R.; Lin, D.; Wu, X.; Lin, Q.; Wu, X.; Zheng, J.; Pan, X.; Peng, J.; et al. Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells. Cancer Chemother. Pharmacol. 2005, 56, 400-408.
33. Chaykovska, L.; Alter, M.L.; von Websky, K.; Hohmann, M.; Tsuprykov, O.; Reichetzeder, C.; Kutil, B.; Kraft, R.; Klein, T.; Hocher, B. Effects of telmisartan and linagliptin when used in combination on blood pressure and oxidative stress in rats with 2-kidney-1-clip hypertension. J. Hypertens. 2013, 31, 2290-2299.
34. Siragusa, M.; Sessa, W.C. Telmisartan exerts pleiotropic effects in endothelial cells and promotes endothelial cell quiescence and survival. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 1852-1860.
35. Chen, Y.; Luo, Q.; Xiong, Z.; Liang, W.; Chen, L.; Xiong, Z. Telmisartan counteracts TGF-β1 induced epithelial-to-mesenchymal transition via PPAR-? in human proximal tubule epithelial cells. Int. J. Clin. Exp. Pathol. 2012, 5, 522-529.
36. Shigeto, T.; Yokoyama, Y.; Xin, B.; Mizunuma, H. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer. Oncol. Rep. 2007, 18, 833-840.
37. Wei, D.; Peng, J.J.; Gao, H.; Li, H.; Li, D.; Tan, Y.; Zhang, T. Digoxin Downregulates NDRG1 and VEGF through the Inhibition of HIF-1a under Hypoxic Conditions in Human Lung Adenocarcinoma A549 Cells. Int. J. Mol. Sci. 2013, 14, 7273-7285.
38. Tang, Z.P.; Cui, Q.Z.; Dong, Q.Z.; Xu, K.; Wang, E.H. Ataxia-telangiectasia group D complementing gene (ATDC) upregulates matrix metalloproteinase 9 (MMP-9) to promote lung cancer cell invasion by activating ERK and JNK pathways. Tumour Biol. 2013, 34, 2835-2842.
39. Karami, H.; Baradaran, B.; Esfahani, A.; Estiar, M.A.; Naghavi-Behzad, M.; Sakhinia, M.; Sakhinia, E. siRNA-Mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells. Asian Pac. J. Cancer Prev. 2013, 14, 7719-7724.